Cutaneous adverse reaction to infliximab : Report of psoriasis developing in 3 patients

Infliximab is a chimeric immunoglobulin G1kappa monoclonal antibody against tumor necrosis factor alpha (TNF-alpha), a proinflammatory cytokine that participates in both normal immune function and the pathogenesis of many autoimmune disorders. Treatment with infliximab reduces the biologic activitie...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Cutis (New York, N.Y.) N.Y.), 2007-09, Vol.80 (3), p.231-237
Hauptverfasser:	SEVERS, Gregg A, LAWLOR, Tara H, PURCELL, Stephen M, ADLER, Donald J, THOMPSON, Robert
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Antibodies, Monoclonal - adverse effects Biological and medical sciences Dermatology Female Gastrointestinal Agents - adverse effects Humans Inflammatory Bowel Diseases - drug therapy Infliximab Male Medical sciences Psoriasis - chemically induced Psoriasis. Parapsoriasis. Lichen
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!